BioSpace News Archive

Pharm Country

Deerfield Management Closes $840 Million Venture Capital Fund

The fund will focus on investing in science startups related to new therapies and technology related to “improve the way healthcare is delivered to patients.”

April 7, 2020
·
3 min read
·
Mark Terry
BioMidwest

The Hopes and Challenges of a COVID-19 Vaccine

While the world is working to slow the COVID-19 pandemic by social isolation and quarantine, numerous companies globally are working to develop a vaccine against the virus.

April 7, 2020
·
5 min read
·
Mark Terry
Drug Development

Wellcome Trust Aims to Raise $8 Billion to Battle COVID-19 Pandemic

It would be used to fill in the gaps seen in funding for vaccines, treatments and diagnostic testing.

April 7, 2020
·
2 min read
·
Mark Terry
Study Shows Possible Alternative Treatment for High-Grade Glioma Tumors in Infants

“It’s especially cruel when cancer affects such small children, so it is encouraging that this study offers some hope for very young patients and their families,” said Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London.

April 7, 2020
·
3 min read
·
Michelle Brugioni
Business

Gilead Sciences, Second Genome Pair Up in Microbiome Research Pact Worth up to $1.5 Billion

Gilead Sciences and Second Genome forged a four-year strategic collaboration that will boost chances to discover and develop new targets and drug candidates for the treatment of inflammatory bowel disease through microbiome research.

April 7, 2020
·
2 min read
·
Alex Keown
Policy

Biopharma Update on the Novel Coronavirus: April 7

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 7, 2020.

April 7, 2020
·
6 min read
·
BioSpace Editorial Staff
Business

CDC Confirms COVID-19 is Less Severe in Pediatric Patients

The CDC findings were based on an analysis of 2,572 known juvenile cases of COVID-19 that were part of a batch of 149,760 laboratory-confirmed COVID-19 cases.

April 7, 2020
·
2 min read
·
Alex Keown
BioForest

Comparison: COVID-19 Innovations in the U.S. Versus the Rest of the World

The United States leads the world in biotech innovation, but does it also lead the world in the development of COVID-19 diagnostics, vaccines and therapeutics?

April 7, 2020
·
5 min read
·
Gail Dutton
Pharm Country

Q BioMed Enters into a Financial Restructuring of Approximately $7,800,000 Consisting of $4,000,000 New Cash and a Minimum of $3,800,000 of Debt Conversion

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today the entering of a significant financial transaction with its lead investor, Yorkville Advisors Global (“YA”).

April 7, 2020
·
3 min read
FDA Accelerates Development of Novel Therapies for COVID-19

The U.S. Food and Drug Administration has taken an all-hands-on-deck approach across public, academic and private sectors to combat the COVID-19 pandemic. The new program is designed to expedite the development of potentially safe and effective life-saving treatm

April 7, 2020
·
11 min read